{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:41:26Z","timestamp":1790890886328,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05531-y","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T10:02:39Z","timestamp":1708682559000},"page":"749-755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7948-5394","authenticated-orcid":false,"given":"Tatjana","family":"Zeki\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7848-6600","authenticated-orcid":false,"given":"Andrej","family":"Belan\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"5531_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","volume":"23","author":"JY Dabit","year":"2022","unstructured":"Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S, Duarte-Garc\u00eda A (2022) Epidemiology of antiphospholipid syndrome in the general population. Curr Rheumatol Rep 23:85. https:\/\/doi.org\/10.1007\/s11926-021-01038-2","journal-title":"Curr Rheumatol Rep"},{"key":"5531_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.14740\/jocmr4154","volume":"12","author":"DC Oliveira","year":"2020","unstructured":"Oliveira DC, Correia A, Oliveira C (2020) The issue of the antiphospholipid antibody syndrome. J Clin Med Res 12:286\u2013292. https:\/\/doi.org\/10.14740\/jocmr4154","journal-title":"J Clin Med Res"},{"key":"5531_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.prp.2018.10.020","volume":"215","author":"A Belan\u010di\u0107","year":"2019","unstructured":"Belan\u010di\u0107 A, Vrani\u0107 L, \u0160eveljevi\u0107 I et al (2019) Antiphospholipid antibodies associated with nodal marginal zone lymphoma and its progression to diffuse large B-cell lymphoma\u2014a case report. Pathol Res Pract 215:222\u2013228. https:\/\/doi.org\/10.1016\/j.prp.2018.10.020","journal-title":"Pathol Res Pract"},{"key":"5531_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","volume":"80","author":"S Akiyama","year":"2021","unstructured":"Akiyama S, Hamdeh S, Micic D, Sakuraba A (2021) Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis 80:384\u2013391. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218946","journal-title":"Ann Rheum Dis"},{"key":"5531_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00296-021-04803-9","volume":"41","author":"Q Wang","year":"2021","unstructured":"Wang Q, Liu J, Shao R et al (2021) Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis. Rheumatol Int 41:851\u2013861. https:\/\/doi.org\/10.1007\/s00296-021-04803-9","journal-title":"Rheumatol Int"},{"key":"5531_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S et al (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 79:859\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871","journal-title":"Ann Rheum Dis"},{"key":"5531_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","volume":"80","author":"A Strangfeld","year":"2021","unstructured":"Strangfeld A, Sch\u00e4fer M, Gianfrancesco MA et al (2021) Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 80:930\u2013942. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219498","journal-title":"Ann Rheum Dis"},{"key":"5531_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00320-9","volume":"3","author":"S Sciascia","year":"2021","unstructured":"Sciascia S, Costanzo P, Radin M et al (2021) Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies. Lancet Rheumatol 3:e832. https:\/\/doi.org\/10.1016\/S2665-9913(21)00320-9","journal-title":"Lancet Rheumatol"},{"key":"5531_CR9","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1007\/s10067-022-06253-5","volume":"41","author":"CA Isnardi","year":"2022","unstructured":"Isnardi CA, Schneeberger EE, Kreimer JL et al (2022) An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data. Clin Rheumatol 41:3199\u20133209. https:\/\/doi.org\/10.1007\/s10067-022-06253-5","journal-title":"Clin Rheumatol"},{"key":"5531_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.769254","volume":"12","author":"FJ Gonzalez-Gonzalez","year":"2021","unstructured":"Gonzalez-Gonzalez FJ, Ziccardi MR, McCauley MD (2021) Virchow\u2019s triad and the role of thrombosis in COVID-related stroke. Front Physiol 12:769254. https:\/\/doi.org\/10.3389\/fphys.2021.769254","journal-title":"Front Physiol"},{"key":"5531_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/2046-4053-2-115","volume":"2","author":"WM Bramer","year":"2013","unstructured":"Bramer WM, Giustini D, Kramer BM, Anderson P (2013) The comparative recall of Google Scholar versus PubMed in identical searches for biomedical systematic reviews: a review of searches used in systematic reviews. Syst Rev 2:115. https:\/\/doi.org\/10.1186\/2046-4053-2-115","journal-title":"Syst Rev"},{"key":"5531_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1096\/fj.07-9492LSF","volume":"22","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Pitsouni EI, Malietzis GA, Pappas G (2008) Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J 22:338\u2013342. https:\/\/doi.org\/10.1096\/fj.07-9492LSF","journal-title":"FASEB J"},{"key":"5531_CR13","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","volume":"159","author":"D Jim\u00e9nez","year":"2021","unstructured":"Jim\u00e9nez D, Garc\u00eda-Sanchez A, Rali P et al (2021) Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest 159:1182\u20131196. https:\/\/doi.org\/10.1016\/j.chest.2020.11.005","journal-title":"Chest"},{"key":"5531_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41569-021-00665-7","volume":"19","author":"DA Gorog","year":"2022","unstructured":"Gorog DA, Storey RF, Gurbel PA et al (2022) Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol 19:475\u2013495. https:\/\/doi.org\/10.1038\/s41569-021-00665-7","journal-title":"Nat Rev Cardiol"},{"key":"5531_CR15","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/clc.23460","volume":"43","author":"JL Mehta","year":"2020","unstructured":"Mehta JL, Calcaterra G, Bassareo PP (2020) COVID-19, thromboembolic risk, and Virchow\u2019s triad: lesson from the past. Clin Cardiol 43:1362\u20131367. https:\/\/doi.org\/10.1002\/clc.23460","journal-title":"Clin Cardiol"},{"key":"5531_CR16","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1177\/09612033211062523","volume":"30","author":"X Wang","year":"2021","unstructured":"Wang X, Gkrouzman E, Andrade DCO et al (2021) COVID-19 and antiphospholipid antibodies: a position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION). Lupus 30:2276\u20132285. https:\/\/doi.org\/10.1177\/09612033211062523","journal-title":"Lupus"},{"key":"5531_CR17","unstructured":"https:\/\/www.eular.org\/web\/static\/lib\/pdfjs\/web\/viewer.html?file=https:\/\/www.eular.org\/document\/download\/236\/ef4df565-002e-4213-96c0-5ef67b02f878\/282"},{"key":"5531_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065644","author":"O Ott","year":"2023","unstructured":"Ott O, Herrmann E, Schulz A, Lindhoff-Last E (2023) The APSANTICO Study: a prospective observational study to evaluate antiphospholipid antibody profiles in patients with thromboembolic antiphospholipid syndrome (APS) after COVID-19 infection and\/or vaccination. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24065644","journal-title":"Int J Mol Sci"},{"key":"5531_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11926-020-00971-y","volume":"23","author":"GE Fitzgerald","year":"2021","unstructured":"Fitzgerald GE, Maguire S, Haroon N (2021) COVID-19: what do rheumatologists need to know? Curr Rheumatol Rep 23:5. https:\/\/doi.org\/10.1007\/s11926-020-00971-y","journal-title":"Curr Rheumatol Rep"},{"key":"5531_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030735","author":"NR Tumian","year":"2022","unstructured":"Tumian NR, Hunt BJ (2022) Clinical management of thrombotic antiphospholipid syndrome. J Clin Med Res. https:\/\/doi.org\/10.3390\/jcm11030735","journal-title":"J Clin Med Res"},{"key":"5531_CR21","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.42624","volume":"75","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R et al (2023) The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol 75:1687\u20131702. https:\/\/doi.org\/10.1002\/art.42624","journal-title":"Arthritis Rheumatol"},{"key":"5531_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001580","author":"M Taha","year":"2021","unstructured":"Taha M, Samavati L (2021) Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2021-001580","journal-title":"RMD Open"},{"key":"5531_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","volume":"191","author":"C Lodigiani","year":"2020","unstructured":"Lodigiani C, Iapichino G, Carenzo L et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9\u201314. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.024","journal-title":"Thromb Res"},{"key":"5531_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.2338","volume":"6","author":"MC Fang","year":"2023","unstructured":"Fang MC, Reynolds K, Tabada GH et al (2023) Assessment of the risk of venous thromboembolism in nonhospitalized patients with COVID-19. JAMA Netw Open 6:e232338. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.2338","journal-title":"JAMA Netw Open"},{"key":"5531_CR25","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","volume":"69","author":"MT Corban","year":"2017","unstructured":"Corban MT, Duarte-Garcia A, McBane RD et al (2017) Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics. J Am Coll Cardiol 69:2317\u20132330. https:\/\/doi.org\/10.1016\/j.jacc.2017.02.058","journal-title":"J Am Coll Cardiol"},{"key":"5531_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11926-021-01008-8","volume":"23","author":"D Erkan","year":"2021","unstructured":"Erkan D, Sciascia S, Bertolaccini ML et al (2021) Antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION): 10-year update. Curr Rheumatol Rep 23:45. https:\/\/doi.org\/10.1007\/s11926-021-01008-8","journal-title":"Curr Rheumatol Rep"},{"key":"5531_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010211","author":"M Ogri\u010d","year":"2022","unstructured":"Ogri\u010d M, \u017digon P, Sodin-Semrl S et al (2022) Longitudinal analysis of antiphospholipid antibody dynamics after infection with SARS-CoV-2 or vaccination with BNT162b2. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24010211","journal-title":"Int J Mol Sci"},{"key":"5531_CR28","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/art.41777","volume":"73","author":"N Gendron","year":"2021","unstructured":"Gendron N, Dragon-Durey M-A, Chocron R et al (2021) Lupus anticoagulant single positivity during the acute phase of COVID-19 Is not associated with venous thromboembolism or in-hospital mortality. Arthritis Rheumatol 73:1976\u20131985. https:\/\/doi.org\/10.1002\/art.41777","journal-title":"Arthritis Rheumatol"},{"key":"5531_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100041","volume":"7","author":"A Mendel","year":"2023","unstructured":"Mendel A, Fritzler MJ, St-Pierre Y et al (2023) Outcomes associated with antiphospholipid antibodies in COVID-19: a prospective cohort study. Res Pract Thromb Haemost 7:100041. https:\/\/doi.org\/10.1016\/j.rpth.2023.100041","journal-title":"Res Pract Thromb Haemost"},{"key":"5531_CR30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Bai H, Chen X et al (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18:1094\u20131099. https:\/\/doi.org\/10.1111\/jth.14817","journal-title":"J Thromb Haemost"},{"key":"5531_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3892\/ijmm.2020.4659","volume":"46","author":"E Cavalli","year":"2020","unstructured":"Cavalli E, Bramanti A, Ciurleo R et al (2020) Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: diagnostic and therapeutic perspectives (review). Int J Mol Med 46:903\u2013912. https:\/\/doi.org\/10.3892\/ijmm.2020.4659","journal-title":"Int J Mol Med"},{"key":"5531_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","volume":"24","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH, Connors JM et al (2020) The unique characteristics of COVID-19 coagulopathy. Crit Care 24:360. https:\/\/doi.org\/10.1186\/s13054-020-03077-0","journal-title":"Crit Care"},{"key":"5531_CR33","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00296-021-04980-7","volume":"42","author":"G Otar Yener","year":"2022","unstructured":"Otar Yener G, Pa\u00e7K\u0131saarslan A, Ulu K et al (2022) Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study. Rheumatol Int 42:879\u2013889. https:\/\/doi.org\/10.1007\/s00296-021-04980-7","journal-title":"Rheumatol Int"},{"key":"5531_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2022.101402","volume":"35","author":"A Butt","year":"2022","unstructured":"Butt A, Erkan D, Lee AI (2022) COVID-19 and antiphospholipid antibodies. Best Pract Res Clin Haematol 35:101402. https:\/\/doi.org\/10.1016\/j.beha.2022.101402","journal-title":"Best Pract Res Clin Haematol"},{"key":"5531_CR35","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","volume":"7","author":"PL Meroni","year":"2011","unstructured":"Meroni PL, Borghi MO, Raschi E, Tedesco F (2011) Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 7:330\u2013339. https:\/\/doi.org\/10.1038\/nrrheum.2011.52","journal-title":"Nat Rev Rheumatol"},{"key":"5531_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaa081","volume":"5","author":"ML Tung","year":"2021","unstructured":"Tung ML, Tan B, Cherian R, Chandra B (2021) Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract 5:rkaa081. https:\/\/doi.org\/10.1093\/rap\/rkaa081","journal-title":"Rheumatol Adv Pract"},{"key":"5531_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687534","volume":"12","author":"S Sciascia","year":"2021","unstructured":"Sciascia S, Radin M, Bazzan M et al (2021) Antiphospholipid antibodies and infection: non nova sed nove. Front Immunol 12:687534. https:\/\/doi.org\/10.3389\/fimmu.2021.687534","journal-title":"Front Immunol"},{"key":"5531_CR38","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00296-023-05319-0","volume":"43","author":"Y Fedorchenko","year":"2023","unstructured":"Fedorchenko Y, Zimba O (2023) Long COVID in autoimmune rheumatic diseases. Rheumatol Int 43:1197\u20131207. https:\/\/doi.org\/10.1007\/s00296-023-05319-0","journal-title":"Rheumatol Int"},{"key":"5531_CR39","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/annrheumdis-2021-221490","volume":"81","author":"PM Machado","year":"2022","unstructured":"Machado PM, Lawson-Tovey S, Strangfeld A et al (2022) Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Ann Rheum Dis 81:695\u2013709. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221490","journal-title":"Ann Rheum Dis"},{"key":"5531_CR40","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1177\/09612033221102073","volume":"31","author":"F Signorelli","year":"2022","unstructured":"Signorelli F, Balbi GGM, Aikawa NE et al (2022) Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. Lupus 31:974\u2013984. https:\/\/doi.org\/10.1177\/09612033221102073","journal-title":"Lupus"},{"key":"5531_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/rheumatology\/keac400","volume":"62","author":"H Pan","year":"2023","unstructured":"Pan H, Tang Z, Teng J et al (2023) COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study. Rheumatology 62:829\u2013834. https:\/\/doi.org\/10.1093\/rheumatology\/keac400","journal-title":"Rheumatology"},{"key":"5531_CR42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/1756-185X.14490","volume":"26","author":"\u00d6 Karaka\u015f","year":"2023","unstructured":"Karaka\u015f \u00d6, Erden A, Arma\u011fan B et al (2023) Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: a retrospective cohort study. Int J Rheum Dis 26:292\u2013297. https:\/\/doi.org\/10.1111\/1756-185X.14490","journal-title":"Int J Rheum Dis"},{"key":"5531_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cytogfr.2021.05.001","volume":"60","author":"R Talotta","year":"2021","unstructured":"Talotta R, Robertson ES (2021) Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: the straw that breaks the camel\u2019s back? Cytokine Growth Factor Rev 60:52\u201360. https:\/\/doi.org\/10.1016\/j.cytogfr.2021.05.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"5531_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729251","volume":"12","author":"C Bilotta","year":"2021","unstructured":"Bilotta C, Perrone G, Adelfio V et al (2021) COVID-19 vaccine-related thrombosis: a systematic review and exploratory analysis. Front Immunol 12:729251. https:\/\/doi.org\/10.3389\/fimmu.2021.729251","journal-title":"Front Immunol"},{"key":"5531_CR45","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMe2106315","volume":"384","author":"DB Cines","year":"2021","unstructured":"Cines DB, Bussel JB (2021) SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. N Engl J Med 384:2254\u20132256","journal-title":"N Engl J Med"},{"key":"5531_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102941","volume":"20","author":"F Elrashdy","year":"2021","unstructured":"Elrashdy F, Tambuwala MM, Hassan SS et al (2021) Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmun Rev 20:102941. https:\/\/doi.org\/10.1016\/j.autrev.2021.102941","journal-title":"Autoimmun Rev"},{"key":"5531_CR47","doi-asserted-by":"publisher","first-page":"SI136","DOI":"10.1016\/j.autrev.2021.102941","volume":"61","author":"V Pengo","year":"2022","unstructured":"Pengo V, Del Ross T, Tonella M et al (2022) Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey. Rheumatology 61:SI136\u2013SI142. https:\/\/doi.org\/10.1016\/j.autrev.2021.102941","journal-title":"Rheumatology"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05531-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05531-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05531-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T04:27:21Z","timestamp":1711772841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05531-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["5531"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05531-y","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"assertion":[{"value":"3 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This narrative review is written in compliance with ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}